Work

Cost-effectiveness analysis of neoadjuvant immune checkpoint inhibition vs. cisplatin-based chemotherapy in muscle invasive bladder cancer

Year: 2021

Type: article

Source: Urologic Oncology Seminars and Original Investigations

DOI: 10.1016/j.urolonc.2021.03.004

Authors: Ali Raza Khaki, Yong Shan, Richard E Nelson, Sapna Kaul, John L Gore, Petros Grivas, Stephen B Williams

Institutions: Seattle Cancer Care Alliance, University of Washington, Fred Hutch Cancer Center, Stanford University, The University of Texas Medical Branch at Galveston, University of Utah, VA Salt Lake City Healthcare System

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Defense, National Cancer Institute

Award: Training in cancer biology and transplantation

OpenAlex ID: W3136123238

FWCI: 2.114

Cites: 36

Cited by: 18

Related to: 10